Immunology Biosimilars Market 2019 Top 20 Key Players, Size Estimation, Industry Share, Business Analysis and Growth Forecast to 2026

Jun 7, 2019

Immunology Biosimilars Market 2019 | Clinical Analysis, Latest Innovations, Impacting Factors, Growth opportunities, Drivers, Dynamics And Strategic Research, Challenges By 2026

June 7, 2019 /MarketersMedia/ —

Increasing cases of tumor or diseases such as arthritis and others is expected to propel growth in the global immunology biosimilars market. Fortune Business Insights studies the market in detail in a report, titled “Immunology Biosimilars Market Size, Share and Global Trend By Disease (Inflammatory Bowel Disease, Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Geography Forecast till 2026.” According to the report, in 2018 North America held a considerable share in the market.

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/sample/immunology-biosimilars-market-100200

North America is expected to witness promising growth during the forecast period 2019-2026. Increasing approvals in the region for immunology biosimilars product development is likely to contribute towards market growth. Additionally, intense research and development (R&D) activities and clinical trial being conducted in nations such as the U.S and Canada are foreseen to enable growth in the global market. Besides this, the immunology biosimilars market in Europe is foreseen to witness impressive growth. Increasing adoption of biosimilars in nations such as Germany, the U.K., France, and others is likely to increase the growth rate in market.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

• Novartis AG,
• Pfizer Inc.,
• Mylan N.V.,
• AbbVie Inc.,
• STADA Arzneimittel AG,
• Celltrion, Inc.,
• KBI Biopharma, Inc.,
• Amgen Inc

Asia Pacific is anticipated to expand at a faster CAGR. Japan offers a lot of opportunity for immunology biosimilars. Owing to receiving the approval of eight biosimilars in Japan since 2016, the market is foreseen to witness growth. Furthermore, high usage of biosimilars in other application such as rheumatoid arthritis is expected to encourage the adoption of biosimilar drugs.

The report also classifies the market on the basis of disease, into arthritis, inflammatory bowel disease, and others. At present inflammatory bowel disease and arthritis together account for major portion of the market. The segments are anticipated to expand during the forecast period 2019-2026. Owing to the cost effectiveness of biosimilar they have become the preferred method to treat these diseases. This would also boost the global immunology biosimilars market.

Request Customization of this Report@ https://www.fortunebusinessinsights.com/enquiry/customization/immunology-biosimilars-market-100200

Increasing Healthcare Expenditure to Drive the Market

Cheaper pricing of biosimilar drugs compared to biologics and increasing healthcare expenditure are some factors expected to drive the market. Moreover, expiry of patents of some biologics such as Humira, Enbrel, and others is likely to fuel the demand for biosimilar drugs.

Complex manufacturing process of biosimilars and stringent regulations for approval of biosimilar products are some key factors that may restrain the market. Moreover, slow adoption of biosimilar in developing nations is hampering the growth rate in the market.

Market is Witnessing Frequent Product Launch

The immunology biosimilar of UDENYCA (pegfilgrastim-cbqv) received approval from the Food and Drug Administration in 2018. The product was developed by Coherus Biosciences and KBI Biopharma, Inc. and its reference product is Neulasta. Certain development is expected to contribute towards faster adoption of biosimilars.

ByDistribution Channel:
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies

By Geography:
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Browse Full Report@ https://www.fortunebusinessinsights.com/industry-reports/immunology-biosimilars-market-100200

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]

Contact Info:
Name: Mr. Ajay More
Email: Send Email
Organization: Fortune Business Insights
Website: https://www.fortunebusinessinsights.com/

Source URL: https://marketersmedia.com/immunology-biosimilars-market-2019-top-20-key-players-size-estimation-industry-share-business-analysis-and-growth-forecast-to-2026/521331

Source: MarketersMedia

Release ID: 521331

More News

Kelana Jaya LRT route disruption: Rapid Rail restoring service

Oct 15, 2024

Kelana Jaya LRT route disruption: Rapid Rail restoring service

KUALA LUMPUR: Repair works are being carried out following a service disruption on the Kelana Jaya LRT Line, involving the track between Wangsa Maju and Sri Rampai Stations, which was caused by an unusual flow of rainwater that damaged several track components, said Rapid Rail Sdn Bhd (Rapid Rail). Rapid Rail as the operator of the Rapid KL rail service in a statement said that the incident occurred at 10.20 am which forced the operation to stop the power supply in the area involved to allow inspection and repair work to be carried out. “Repair works are being actively carried out by Rapid Rail’s technical team to ensure that services can be restored soon,“ according to the statement. For now, a feeder service has been activated between Gombak Station and Wangsa Maju Station. Trains from the direction of Putra Heights will turn back at Wangsa Maju Station. A total of 12 free feeder buses at a frequency of every 15 minutes are operating to ensure that passengers can continue their journey. “We hope that this repair work can be completed before the evening peak hour,“ said Rapid Rail. In addition, operation staff and auxiliary police personnel have been stationed at the stations involved to help facilitate the movement of affected passengers. Continuous announcements on the development of service status will be delivered through Rapid KL’s social media, at all stations, and on trains. Rapid Rail also informed that the latest development of service status will be announced at 3 pm. “Passengers are advised to plan their journeys and refer to Rapid KL’s social media to get the latest information on the service status of the Kelana Jaya LRT Line,“ said the statement. For more information, the public can contact Rapid Rail’s communications officer, Noor Natasha Mohd Irwan at 013-332 2900. Several roads in Kuala Lumpur were flooded following the continuous heavy rain that started at about 9 this morning.

12,519 cases under Weights and Measures Act recorded as of September - KPDN

Oct 15, 2024

12,519 cases under Weights and Measures Act recorded as of September - KPDN

SHAH ALAM: A total of 12,519 cases involving offences under the Weights and Measures Act (ATS) 1972 were recorded by the enforcement division of the Ministry of Domestic Trade and Cost of Living (KPDN) nationwide from 2020 to September this year. KPDN deputy-director of Enforcement (Prevention) Aris Mamat said the statistics reflected the ministry’s ongoing and proactive efforts to ensure that traders adhered to the integrity of weights and measures in buying and selling for the benefit of consumers. “KPDN is committed to protecting consumers and consistently ensuring that traders adhere to established standards. Those found to have committed irregularities or non-compliance will not evade strict enforcement actions. “A violation of the provisions under the ATS 1972 could result in a maximum fine of RM40,000, imprisonment for up to three years, or both, and the court may also order the forfeiture of the weighing instrument,” he said today. He said this after heading a team of 20 KPDN enforcement officers to perform spot checks at three petrol stations around Kuala Selangor to ensure that the fuel charged to consumers matched the amount supplied through pump dispensers. Elaborating, Aris said that the ATS 1972 enforcement compliance inspections at petrol stations led to actions against the misuse of subsidised diesel fuel under Ops Tiris, resulting in the seizure of diesel valued at approximately RM16.5 million from January to September this year. “This brings the total amount of diesel seized from 2020 to 2024 to RM52.68 million,” he said. Commenting on today’s operation, Aris said that it focused on several key aspects, including the accuracy of oil pumps and meters, testing the volume of fuel dispensed, and reviewing the maintenance records of weighing and measuring equipment. He added that checks revealed all the petrol stations involved complied with the weighing and measuring regulations set. “Regarding the enforcement actions under the ATS 1972 in Selangor, we recorded a total of 283 cases from January to September last year, with confiscated items amounting to RM2.6 million,” he said.

Skills-related underemployment shows declining trend

Oct 15, 2024

Skills-related underemployment shows declining trend

KUALA LUMPUR: The skills-related underemployment (SRU) rate has continued to fall in line with improvements in the country’s education level, said Deputy Economy Minister Datuk Hanifah Hajar Taib. SRU is defined as tertiary-educated individuals working in semi-skilled and low-skilled jobs. Hanifah said the SRU rate stood at 37% in the second quarter of 2024, in line with high-income nations such as South Korea (38%), Australia (32%), the United Kingdom (28%), and the United States (30%). “The underemployment rate of STPM holders is 55.8%, while for degree holders, the rate is lower at 26.9%,” she said during the question-and-answer session in the Dewan Rakyat today. She was responding to a supplementary question from Datuk Mohd Shahar Abdullah (BN-Paya Besar) on the government’s efforts to address the mismatch between labour supply and demand, particularly among graduates with a cumulative grade point average (CGPA) of 3.5 and above who qualify for jobs in high-growth sectors. Hanifah explained that the government is actively trying to boost investments in key sectors to create more high-skilled jobs, with initiatives such as the KL20 Action Plan, the National Energy Transition Roadmap, and the New Industrial Master Plan 2030. “These measures will ensure that the country’s economy does not only rely on (just providing) low tax rates but also can meet the demand for high-quality jobs,” she said. Hanifah also emphasised the government’s commitment to developing a comprehensive ecosystem that encourages skilled workers abroad to return home, such as from Singapore where the cost of living is rising. “If the cost of living in Singapore becomes too high, skilled workers might consider returning to Malaysia, where the job ecosystem and quality of life better suit their needs,“ she noted. She added that the government is ready to strengthen upskilling and reskilling initiatives to ensure the workforce meets the needs of high-value and high-growth industries.

National Strategic Plan addresses child malnutrition with comprehensive approach

Oct 15, 2024

National Strategic Plan addresses child malnutrition with comprehensive approach

KUALA LUMPUR: KUALA LUMPUR: The 2022-2030 National Strategic Plan to Combat the Double Burden of Malnutrition Among Children in Malaysia will ensure a more comprehensive approach to addressing issues such as stunting and obesity, said Health Minister Datuk Seri Dr Dzulkefly Ahmad. He expressed hope that the plan would expedite efforts to tackle child malnutrition in order to build a healthy nation and nurture healthy Malaysians from a young age. Dzulkefly said the plan, encompassing five core strategies and 31 initiatives, took into account the functions and policies of all ministries and agencies while emphasising the involvement of various parties and the strengthening of existing strategies through cross-cutting approaches. “The plan prioritises strengthening the governance of nutritional well-being through legislation, political commitment, and stakeholder involvement, while also improving the quality and accessibility of nutritional services and creating a more conducive society. “Efforts to strengthen capacity development and human capital for the well-being of children’s nutrition, along with the synergy of child nutrition advocacy, are also emphasised,” he said during the oral question and answer session at Dewan Rakyat today. Dzulkefly said this in response to a question from Datuk Dr Alias Razak (PN-Kuala Nerus) regarding the ministry’s plan to create a master document, such as the Child Nutrition Action Plan, to address the issue of child nutrition. He said the plan aimed to have a specific impact on children, teenagers, women of reproductive age, and vulnerable groups, designed to mobilise energy effectively among all stakeholders in the implementation of strategies, programmes, and outlined activities. “One of the efforts being strengthened is the initiative to support the first 1,000 days of a child’s life, beginning with the first day of pregnancy and lasting until the child is two years old,” he said. Dzulkefly said among the activities conducted were engagement and advocacy sessions for private pharmacies and health clinics to facilitate early screenings. He said that this included conducting blood haemoglobin tests for women and pregnant mothers to reduce the risk of pregnancy complications, enabling them to plan for a healthy pregnancy.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Suara KL

Suara KL brings amazing Travel news for tourist to witness Beautiful Malaysia and hear the wonderful sounds of this country.

Newsletter